Epiruka Tablet 20 mg (Epinastine Hydrochloride)

Adult dose

1. Asthma, urticaria, eczema/dermatitis, pruritus, prurigo, and pruritic psoriasis Adults: Administer 20 mg of epinastine hydrochloride orally once daily. The dose may be adjusted according to symptoms. 2. Allergic rhinitis Adults: Administer 10～20 mg of this drug orally once daily. The dose may be adjusted according to symptoms.

This medication should not be used in patients who have an allergic reaction to it or its components. Additionally, since it contains lactose, it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption. Patients with liver disease or a history of liver disease should be cautious as their liver condition may worsen when using this medication. If allergic symptoms such as rash, urticaria, swelling of the face, hands, or feet, or severe itching occur while using this medication, discontinue taking the medicine immediately and seek medical attention. This medication can cause neurological side effects such as drowsiness, headache, dizziness, and insomnia, so caution should be exercised when driving or operating machinery. Gastrointestinal symptoms such as nausea, abdominal pain, diarrhea, and constipation may rarely occur, so if symptoms are severe, consult a healthcare professional. It is important to periodically monitor liver health since liver dysfunction or jaundice symptoms may appear. Rarely, abnormal symptoms may occur in the kidneys or urinary system, so report any unusual symptoms immediately. This medication is not a fast-acting remedy for asthma attacks, so its use should be carefully explained to asthma patients. Care should be taken to avoid continuing use if there is no effect with prolonged usage, and it is advisable for seasonal allergy patients to start taking it before symptoms begin. Pregnant or potentially pregnant women should use this medication only when absolutely necessary and under a physician's guidance, as its impact on the fetus is not fully understood. Nursing mothers should avoid using this medication if possible, or consult a doctor before making a decision since it may be transmitted through breast milk. The safety for children or infants has not been sufficiently established, so caution is required in its use. Elderly patients may have decreased liver and kidney function, so it is important to carefully observe for adverse reactions and adjust the dosage as necessary. In case of overdose, serious side effects such as arrhythmias may occur, so special care must be taken not to exceed the prescribed dose and to visit a medical institution immediately if any unusual symptoms arise. This medication should be kept out of the reach of children and should not be transferred to another container to ensure safety and maintain quality.

Allergic reactions (rash, hives, redness), itching, swelling (face, limbs, etc.), erythema accompanied by itching, drowsiness, lethargy, headache, dizziness, insomnia, nightmares, numbness, feeling of fogginess in the head, nausea, discomfort in the stomach, dry mouth, abdominal pain, loss of appetite, vomiting, heaviness in the stomach, feeling of fullness in the stomach, diarrhea, constipation, dry lips, abdominal bloating, stomatitis, liver dysfunction, jaundice, hepatitis, exacerbation of symptoms, proteinuria, frequent urination, hematuria, urinary retention, palpitations, shortness of breath, difficulty in expectoration, nasal congestion, thrombocytopenia, leukocytosis, gynecomastia, breast enlargement, menstrual irregularities, flushing, bitter taste, taste impairment, chest pain

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the efficacy of the medication for a longer period.

Appearance

White or pale yellow round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle